China

Essential Guide to China Food Labeling Compliance

Learn the key requirements for China food labeling compliance: mandatory label content, ingredient declarations, imported food requirements, and more.

July 14, 2026
Essential Guide to China Food Labeling Compliance
China NMPA Fee Catalogue for Drugs & Medical Devices

Learn the latest China NMPA registration fees for imported and domestic drugs and medical devices.

July 10, 2026
China NMPA Fee Catalogue for Drugs & Medical Devices
A close-up of an eye with a transparent intraocular lens held by surgical tweezers positioned in front of the pupil, illustrating ophthalmic medical device use. The visual supports themes of regulatory compliance, product registration, and market access
How to Enter China’s Intraocular Lens (IOL) Market: NMPA Registration Requirements for Foreign Manufacturers

Understand the pathway for intraocular lens (IOL) registration in China, including NMPA requirements and key compliance steps.

July 9, 2026
How to Enter China’s Intraocular Lens (IOL) Market: NMPA Registration Requirements for Foreign Manufacturers
A Complete Guide to China Hyaluronic Acid Registration

A complete guide to China hyaluronic acid registration, covering classification, NMPA requirements, and compliance steps for manufacturers.

July 9, 2026
A Complete Guide to China Hyaluronic Acid Registration
A Regulatory Glossary for Medical Devices in China

Practical China medical device glossary explaining NMPA terms, with clear comparisons to US FDA and EU MDR terminology.

July 9, 2026
A Regulatory Glossary for Medical Devices in China
Dental procedure in a clinical setting where two masked dental professionals in white lab coats perform an oral examination and treatment on a patient in a dental chair using specialized instruments and suction equipment, illustrating professional healthca
5 Key Considerations for China Dental Medical Device Registration

Learn 5 key steps for China dental medical device registration, covering classification, biocompatibility testing, and legal agent selection.

July 9, 2026
5 Key Considerations for China Dental Medical Device Registration
How China Medical Device Clinical Trial Strategy Affects NMPA Approval Timelines

Learn how a smart clinical trial strategy for medical devices in China can speed up NMPA approval and bring your product to market faster.

July 9, 2026
How China Medical Device Clinical Trial Strategy Affects NMPA Approval Timelines
FAQs for Foreign Manufacturers: China Medical Device & IVD Registration

Get answers to common China medical device and IVD registration questions, from NMPA classification rules to testing and renewal requirements.

July 10, 2026
FAQs for Foreign Manufacturers: China Medical Device & IVD Registration
How China Medical Device Risk Classification Determines NMPA Registration Pathway

Learn how China medical device risk classification works under NMPA rules and see common compliance pitfalls to avoid.

July 9, 2026
How China Medical Device Risk Classification Determines NMPA Registration Pathway
How China IVD Risk Classification Determines Your NMPA Registration Pathway

Learn how China IVD risk classification works under NMPA rules and see common compliance pitfalls to avoid.

July 13, 2026
How China IVD Risk Classification Determines Your NMPA Registration Pathway
China Manufacture License: 4 Common Misconceptions Foreign Manufacturers Should Rethink

Gain clarity on often-misunderstood China Manufacture License (CML) requirements, including SELO approval, demo products, and CSEI audits.

July 9, 2026
China Manufacture License: 4 Common Misconceptions Foreign Manufacturers Should Rethink
How Does GBA Real World Data Support China NMPA Approvals?

Discover how leveraging Real World Data generated in the Greater Bay Area can accelerate market entry for medical products in China.

July 9, 2026
How Does GBA Real World Data Support China NMPA Approvals?
What Is China’s UDI System & How Does It Affect Medical Device Registration?

Learn about China's Unique Device Identification (UDI) system and how to navigate China’s evolving medical device market.

July 9, 2026
What Is China’s UDI System & How Does It Affect Medical Device Registration?
Stock photograph inside a modern medical device manufacturing facility in China, a Chinese quality assurance engineer wearing a cleanroom gown, hair cover, and appropriate cleanroom attire standing beside a production technician.
China Medical Device GMP Readiness: A Checklist for Overseas Manufacturers

Identify China medical device GMP gaps and prepare QMS, supplier, data, and inspection controls before NMPA market entry.

July 2, 2026
China Medical Device GMP Readiness: A Checklist for Overseas Manufacturers
Chinese flag against a blue sky
China’s 15th Five-Year Plan: Implications for Drugs, Medical Devices, & Market Access 

China’s 15th Five-Year Plan signals stronger support for innovative drugs, advanced medical devices, reimbursement reform, and NMPA regulatory pathways.

May 8, 2026
China’s 15th Five-Year Plan: Implications for Drugs, Medical Devices, & Market Access 
Cisema Logo: Navigating Regulation, Empowering Innovation
Cisema Launches a Redesigned Website

Learn about Cisema’s redesigned website with faster performance, clearer navigation and expanded Asia Pacific coverage.

May 6, 2026
Cisema Launches a Redesigned Website
Graph showing 2026 data for China Class II and Class III medical device approvals
China Medical Device Approval Tracker: Imported Class II & III Devices

Track all imported Class II and III medical device approvals in China with this monthly updated NMPA submission tracker.

April 23, 2026
China Medical Device Approval Tracker: Imported Class II & III Devices
Chinese male MRI technician in a clinical, sterile medical imaging room. The man has a warm, focused expression and is wearing a dark blue medical-style t-shirt

China Expands MRI Registration Requirements Under New 2026 Review Guideline

Manufacturers seeking MRI registration in China must meet expanded technical, software, and validation requirements.

July 16, 2026
China Expands MRI Registration Requirements Under New 2026 Review Guideline

China CMDE Releases New Review Documents for Oncology NGS & HLA-B*58:01 Reagents

The new documents clarify expectations for Tier III variants, companion diagnostic clinical evaluation, tissue and plasma registration, and HLA-B*58:01 analytical validation.

July 16, 2026
China CMDE Releases New Review Documents for Oncology NGS & HLA-B*58:01 Reagents
This stock photo features a close-up, high-angle shot focusing on a skincare product arrangement set against a light-colored, wood-grain surface.

China Updates New Cosmetic Ingredient Registration Rules: Several Higher-Risk Ingredient Categories Removed

New NCI rules reduce administrative burden, streamline dossiers, and expand opportunities to reuse existing safety data.

July 14, 2026
China Updates New Cosmetic Ingredient Registration Rules: Several Higher-Risk Ingredient Categories Removed

China Releases First Regulatory Guidance for Brain-Computer Interface Medical Devices

China's new BCI medical device guidance establishes classification and naming principles, giving manufacturers a clearer pathway to NMPA registration.

July 14, 2026
China Releases First Regulatory Guidance for Brain-Computer Interface Medical Devices

NMPA Opens Consultation on Two Draft Cosmetic Adverse Reaction Standards: Cosmetic Cheilitis & Cosmetic Contact Urticaria

Review China's new draft standards for cosmetic cheilitis and contact urticaria before the August 15, 2026, consultation deadline.

July 13, 2026
NMPA Opens Consultation on Two Draft Cosmetic Adverse Reaction Standards: Cosmetic Cheilitis & Cosmetic Contact Urticaria
An editorial, documentary-style stock photo focuses on the hands of a pharmacist in a white coat handing a printed prescription and a green medication box to an elderly patient across a wooden service counter.

NMPA Releases Guideline on Appropriate Pharmaceutical Packaging Sizes to Reduce Drug Waste & Over-Packaging

New NMPA packaging size guidance encourages drug applicants to align pack sizes with clinical use, patient needs, and sustainability goals.

July 2, 2026
NMPA Releases Guideline on Appropriate Pharmaceutical Packaging Sizes to Reduce Drug Waste & Over-Packaging
A middle-aged Chinese man with graying hair sitting at a wooden desk in a bright home office, looking at an e-commerce pharmacy website on a large computer monitor.

China Tightens Compliance Expectations for Online Prescription Drug Sales

The latest Guidelines raise the compliance bar for online prescription drug sales, with stricter oversight for pharmacies and platforms.

July 2, 2026
China Tightens Compliance Expectations for Online Prescription Drug Sales
A young Chinese male veterinarian wearing dark blue scrubs and black slip-on shoes is crouched down on a shiny white tile floor next to a golden retriever puppy. The vet is smiling directly at the camera while holding a white handheld thermometer.

China Launches Consultation on 5 Veterinary Equipment Standards & New Barcode Rules

Draft standards would introduce a unified 37-digit barcode system and update technical requirements for veterinary equipment supplied to China.

July 2, 2026
China Launches Consultation on 5 Veterinary Equipment Standards & New Barcode Rules
A clinical trial in Hainan, China, inside a clinical research consultation room at a  hospital. A Chinese doctor in a white lab coat seated across from an adult study participant discussing routine trial procedures, a second researcher reviewing data.

Hainan MPA Issues Trial Lecheng Real-World Data Guideline for Imported Drug & Medical Device Registration

New Hainan MPA guidance clarifies how Lecheng real-world evidence can support imported product registration, labeling updates, and post-approval activities

July 2, 2026
Hainan MPA Issues Trial Lecheng Real-World Data Guideline for Imported Drug & Medical Device Registration

China Issues Trial CCC Implementation Rules for Electric Bicycles, Stroller Products, & Toys

New Trial CCC rules strengthen factory oversight, product consistency, and quality management requirements for manufacturers.

July 3, 2026
China Issues Trial CCC Implementation Rules for Electric Bicycles, Stroller Products, & Toys
Stock photo of an adult Chinese man in his 30s standing in a modern supermarket aisle, carefully reading the nutrition and ingredient label on a prepackaged food.

China Revises Pre-Packaged Food Labeling Rules and Digital Labels Under GB 7718-2025

Learn how China's GB 7718-2025 food labeling standard and new digital label rules affect imported foods before the March 2027 compliance deadline.

June 30, 2026
China Revises Pre-Packaged Food Labeling Rules and Digital Labels Under GB 7718-2025
quality control laboratory inside a modern pharmaceutical manufacturing facility in China.

China Revises Drug Clinical Trial GCP to Align with ICH E6(R3)

New rules strengthen data governance and raise sponsor oversight duties from September 2026.

June 29, 2026
China Revises Drug Clinical Trial GCP to Align with ICH E6(R3)

China Strengthens Oversight of Human Genetic Data Through New Ethical Guidelines

New ethics guidelines clarify consent, privacy, security, and governance expectations for human genetic data research in China.

June 29, 2026
China Strengthens Oversight of Human Genetic Data Through New Ethical Guidelines
Chinese customs officer standing beside a single shipping container at a cargo inspection area in China

GACC Updates 2026 Sampling Inspection Scope for Non-Statutory Import & Export Products

China Customs has revised the 2026 sampling inspection program, adding and removing product categories that may face border inspections.

June 18, 2026
GACC Updates 2026 Sampling Inspection Scope for Non-Statutory Import & Export Products

NHC Updates China’s “Three New Foods” List With 16 Newly Approved Substances

China approves new food ingredients, additives, and food-contact materials, creating new formulation and compliance considerations

June 17, 2026
NHC Updates China’s “Three New Foods” List With 16 Newly Approved Substances

NIFDC Publishes 2025 Cosmetics Review Report: 520,000+ Filings, 169 New Ingredients, & Key Reforms

New data on cosmetic registrations, ingredient filings, safety assessments, and standards development reveals key compliance trends in China.

June 16, 2026
NIFDC Publishes 2025 Cosmetics Review Report: 520,000+ Filings, 169 New Ingredients, & Key Reforms
Chinese young professional seated at a table in a modern café, calmly charging a smartphone with a compact power bank connected by a cable

Power Bank Manufacturers Face New CCC Compliance Requirements in China: April 2027 Compliance Deadline

New CCC requirements add GB 47372-2026 as a mandatory certification standard and require certificate conversion for affected products

June 16, 2026
Power Bank Manufacturers Face New CCC Compliance Requirements in China: April 2027 Compliance Deadline
Chinese pharmaceutical scientists and drug development professionals walking through a bright modern pharmaceutical laboratory.

China’s CDE Releases 2025 Drug Evaluation Report

The 2025 Drug Evaluation Report provides insights into key application trends, review activities, and developments across China's pharmaceutical sector.

June 10, 2026
China’s CDE Releases 2025 Drug Evaluation Report

China Unveils Sweeping Reform of Pediatric Drug System

The reformed framework overhauls policy to strengthen innovation while tightening evidence, supply, and compliance requirements.

June 10, 2026
China Unveils Sweeping Reform of Pediatric Drug System

China’s New Pharmaceutical Trial Data Protection Regime: More Than an IP Reform

The framework establishes filing rules, protection scope, and transitional requirements affecting innovative and overseas-originator drug applications in China.

June 10, 2026
China’s New Pharmaceutical Trial Data Protection Regime: More Than an IP Reform
A Chinese adult with diabetes seated at a kitchen table in a bright contemporary apartment, carefully preparing an insulin injection using an insulin pen beside a blood glucose meter and prescription supplies.

China Revises Recombinant Insulin Technical Guideline for Drug Development and Quality Control

The updated technical guideline expands regulatory expectations for manufacturing, impurity control, advanced analytics, stability studies, and biosimilar comparability.

June 2, 2026
China Revises Recombinant Insulin Technical Guideline for Drug Development and Quality Control
Pharmaceutical industry professional walking through a bright modern pharmaceutical facility, wearing business-casual attire and carrying a tablet, surrounded by pharmaceutical workspaces with clean laboratory benches and sealed medicine.

China Issues Revised Measures Governing Pharmaceutical Representatives and Academic Promotion Activities

China’s NMPA and six government agencies issued new measures that strengthen compliance requirements, anti-bribery controls, and oversight of pharmaceutical promotion activities.

June 1, 2026
China Issues Revised Measures Governing Pharmaceutical Representatives and Academic Promotion Activities

China Issues Landmark Regulation on Biomedical New Technologies

The new framework introduces a distinct regulatory pathway for emerging therapies, with major implications for clinical development and market strategy.

June 1, 2026
China Issues Landmark Regulation on Biomedical New Technologies

China Proposes Sweeping New Rules for Drugs, Medical Devices, and Special Foods Advertising

China’s SAMR has released draft advertising review measures that would increase oversight of livestreaming and digital marketing while streamlining certain compliance requirements for regulated products.

June 1, 2026
China Proposes Sweeping New Rules for Drugs, Medical Devices, and Special Foods Advertising
Electrical technician in a modern industrial facility in China holding a low-voltage contactor and visually inspecting it at a workbench

China Updates CCC Certification Requirements for Low-Voltage Electrical Equipment

The three revised CCC certification standards for low-voltage electrical equipment introduce new testing and compliance requirements.

May 29, 2026
China Updates CCC Certification Requirements for Low-Voltage Electrical Equipment
Pharmaceutical scientist in a modern drug development laboratory in China, standing beside a clean laboratory bench while examining a small sample vial and discussing research with a colleague

China CDE Issues Clinical Evaluation Guidelines for Drug Clinical Trial & Marketing Authorization Applications

New guidance highlights the need for earlier China development planning whenrelying on global trials, foreign clinical data, or multinational development strategies

May 29, 2026
China CDE Issues Clinical Evaluation Guidelines for Drug Clinical Trial & Marketing Authorization Applications
Chinese consumer in her early 30s standing in a bright modern bathroom, calmly applying facial moisturizer from a plain unbranded cosmetic container while looking into a mirror.

China Overhauls Cosmetics Import Rules Under GACC Order No. 284

New customs measures taking effect in December 2026 will reshape how cosmetics are inspected, cleared, labeled, and electronically verified in China.

May 29, 2026
China Overhauls Cosmetics Import Rules Under GACC Order No. 284
A consumer electronics and home appliance retail showroom in China, featuring rows of washing machines, washer-dryers, refrigerators, and air conditioners displayed in a bright, upscale store environment. A middle-aged couple carefully compares appliances.

China Releases 2026 Energy Efficiency Label Product Catalogue, Updates Rules for Seven Product Categories

7 product categories will be subject to revised energy efficiency labeling requirements under a phased rollout beginning in June 2026.

May 29, 2026
China Releases 2026 Energy Efficiency Label Product Catalogue, Updates Rules for Seven Product Categories

China Launches Trial Medical Device Vigilance Framework Across 17 Pilot Regions

New measures define vigilance management, inspections, PSURs, trend reporting, and reporting requirements in 17 pilot regions

May 20, 2026
China Launches Trial Medical Device Vigilance Framework Across 17 Pilot Regions
China NMPA Issues New GMP (Good Manufacturing Practice) for Medical Devices

China NMPA Issues New GMP (Good Manufacturing Practice) for Medical Devices

The new GMP for medical devices, effective Nov 1 2026, introduces stricter quality, personnel, and supplier controls.

May 20, 2026
China NMPA Issues New GMP (Good Manufacturing Practice) for Medical Devices
A business professional sits at a conference table using a laptop displaying a glowing digital brain graphic with the text “AI.” The setting appears to be a modern office with large windows and blurred city buildings in the background.

China Launches National AI Roadmap for Pharmaceuticals, Medical Devices, & Cosmetics Supervision

China’s NMPA released a AI roadmap for smarter supervision across drugs, medical devices, and cosmetics regulation, covering AI-supported review, inspections, traceability, risk monitoring, and digital governance through 2035.

May 15, 2026
China Launches National AI Roadmap for Pharmaceuticals, Medical Devices, & Cosmetics Supervision

China's NMPA Updates Medical Device Classification Catalogue, Affecting 31 Categories

China’s NMPA updated the Medical Device Classification Catalogue, revising requirements and classifications for 31 product categories.

May 14, 2026
China's NMPA Updates Medical Device Classification Catalogue, Affecting 31 Categories
Malaysia–China Medical Device Regulatory Reliance Programme: Pilot Phase I Launched

Malaysia–China Medical Device Regulatory Reliance Programme: Pilot Phase I Launched

Malaysia and China launch a regulatory reliance pilot to streamline IVD medical device registration and accelerate cross-border market access.

May 14, 2026
Malaysia–China Medical Device Regulatory Reliance Programme: Pilot Phase I Launched
A young Asian woman in understated casual clothing holding a single unbranded boxed hair dye product slightly angled toward her as she studies the ingredient panel.

China Issues Six Technical Guidelines (Trial) for Hair Dye, Perming, & Sunscreen Cosmetics 

China’s NIFDC releases 6 new technical guidelines for high-risk cosmetics, impacting hair dye, perming, and sunscreen product compliance.

May 8, 2026
China Issues Six Technical Guidelines (Trial) for Hair Dye, Perming, & Sunscreen Cosmetics 
Chinese scientists gathered around a bottle of medicine

China April 2026 Reforms Reshape Drug Approval, Pricing, & Access

The reforms introduce new drug pricing rules, clarified conditional approval procedures, and tiered care measures.

May 8, 2026
China April 2026 Reforms Reshape Drug Approval, Pricing, & Access
dermatology treatment room in a modern Chinese hospital, medium shot: a licensed clinician in medical scrubs and protective eyewear performing a laser skin procedure using a professional Nd:YAG laser system

CMDE Unveils 2026–2027 Roadmap for Medical Device Registration Guidelines, Emphasizing AI, IVDs, and High-Risk Technologies

CMDE maps 275 guideline updates, tightening requirements and giving manufacturers early visibility for planning and compliance.

May 5, 2026
CMDE Unveils 2026–2027 Roadmap for Medical Device Registration Guidelines, Emphasizing AI, IVDs, and High-Risk Technologies
Chinese certification laboratory where two engineers and one compliance inspector are reviewing electrical product samples for CCC certification

CNCA Issues 11 Trial CCC Certification Rules for Fuses and Other Products

CNCA issued 11 trial CCC certification implementation rules for fuses, electric tools, welding machines, automotive components, and safety glass.

May 5, 2026
CNCA Issues 11 Trial CCC Certification Rules for Fuses and Other Products

China’s New AI Ethics Measures Increase Scrutiny of High-Impact AI, Including Health-Related Technologies

China’s MIIT and nine ministries introduce a new AI ethics review and services framework establishing tiered oversight, compliance obligations, and governance pathways for AI activities in China.

April 28, 2026
China’s New AI Ethics Measures Increase Scrutiny of High-Impact AI, Including Health-Related Technologies
Clinician adjusts IV pump in hospital room while colleague records data, illustrating medical device use and compliance.

China Tightens Medical Device Post-Market Surveillance with New Risk Evaluation and Report Review Rules

China issues new guidelines on medical device adverse event risk evaluation and periodic report review, tightening post-market surveillance requirements

April 27, 2026
China Tightens Medical Device Post-Market Surveillance with New Risk Evaluation and Report Review Rules

New NMPA Guideline Defines Registration Requirements for IVUS Systems and Catheters

China’s CMDE releases a new IVUS registration review guideline, defining technical, clinical, and testing requirements for NMPA medical device registration

April 27, 2026
New NMPA Guideline Defines Registration Requirements for IVUS Systems and Catheters
Updates on the Medical Device Classification Catalogue in China

Updates on the Medical Device Classification Catalogue in China: 2020

The NMPA announced a total of 28 updates on the classification catalogue for medical devices including 15 classification changes and 13 content updates.

April 24, 2026
Updates on the Medical Device Classification Catalogue in China: 2020

NMPA Strengthens Cosmetics Oversight with New CBD Testing Methods

China’s NMPA updates cosmetics testing methods, adding CBD detection and tighter impurity controls impacting global compliance.

April 23, 2026
NMPA Strengthens Cosmetics Oversight with New CBD Testing Methods

China Tightens Recall Rules for Cross-Border Food Imports

SAMR introduce stricter recall and compliance requirements for enterprises involved in cross-border e-commerce retail imported food.

April 23, 2026
China Tightens Recall Rules for Cross-Border Food Imports

China NMPA Releases 2025 Medical Device Standardization Management Report

China’s NMPA releases 2025 annual report on medical device standardization, highlighting growth, innovation, and international alignment.

April 23, 2026
China NMPA Releases 2025 Medical Device Standardization Management Report

China NMPA Incorporates 18 Revised Cosmetics Standards Into 2015 Technical Framework

China’s NMPA is incorporating 18 revised cosmetics standards into the Safety and Technical Standards for Cosmetics.

April 23, 2026
China NMPA Incorporates 18 Revised Cosmetics Standards Into 2015 Technical Framework

China NMPA Adds Black Ginseng Extract to IECIC in Third Adjustment

China’s NMPA formally includes black ginseng extract, hydrolyzed sodium hyaluronate zinc, and galactomannan in the IECIC.

April 23, 2026
China NMPA Adds Black Ginseng Extract to IECIC in Third Adjustment

China NMPA Issues 2026 Medical Device Industry Standards Development and Revision Plan

China’s National Medical Products Administration has issued its 2026 medical device standards plan, introducing 80+ new and revised standards

April 23, 2026
China NMPA Issues 2026 Medical Device Industry Standards Development and Revision Plan

China Seeks Comments on Draft 2026 Class III Clinical Trial Approval Catalogue

The draft 2026 catalogue defines which Class III medical devices would require clinical trial approval before trial initiation.

April 23, 2026
China Seeks Comments on Draft 2026 Class III Clinical Trial Approval Catalogue

China NMPA Releases 2025 Medical Device Registration Data Report

China NMPA’s 2025 report highlights growth in medical device approvals, including advanced imported devices.

April 23, 2026
China NMPA Releases 2025 Medical Device Registration Data Report

NMPA CDE Issues MRCT Benefit-Risk Assessment Guideline

China releases guiding principles for benefit-risk assessment using multi-regional clinical trial data to support global drug development.

April 23, 2026
NMPA CDE Issues MRCT Benefit-Risk Assessment Guideline

China NMPA Clarifies Pre-Review for Innovative Device Clinical Trials

China’s NMPA issues new guidance on clinical trial protocol pre-review for innovative devices, impacting overseas fast-track approvals.

April 23, 2026
China NMPA Clarifies Pre-Review for Innovative Device Clinical Trials

China NMPA Introduces New Cosmetic Testing Methods, Effective July 2026

China NMPA adds four new cosmetic testing methods effective July 2026, impacting compliance and safety assessment strategies.

April 23, 2026
China NMPA Introduces New Cosmetic Testing Methods, Effective July 2026
Person standing at a bathroom sink examining a cosmetic tube and applying a small amount of cream to a fingertip, suggesting a skincare routine or product check in a clean, modern setting; relevant to consumer product use and safety evaluation.

China’s NMPA Seeks Public Feedback on First Mandatory Toothpaste Safety Standard

China’s NMPA has opened consultation on a draft mandatory toothpaste safety standard that could tighten product requirements.

April 23, 2026
China’s NMPA Seeks Public Feedback on First Mandatory Toothpaste Safety Standard

NMPA Issues Guidance on Subject Selection for Anti-Tumor Drug BE and PK Studies

China releases new subject selection guidance for anti-tumor drug bioequivalence and pharmacokinetic studies.

April 23, 2026
NMPA Issues Guidance on Subject Selection for Anti-Tumor Drug BE and PK Studies

China Pilots CCC Mark QR Codes for Power Banks, Electric Bicycles, & Gas Appliances

China’s CCC mark pilot reform requires traceability QR codes for power banks, electric bicycles, and gas appliances.

April 23, 2026
China Pilots CCC Mark QR Codes for Power Banks, Electric Bicycles, & Gas Appliances

China Signals Nuclear Market Expansion with HAF003 QA Reform and Global Nuclear Pledge

China's HAF003 reform and participation in the "Tripling Nuclear Energy Declaration" signals stricter compliance and new opportunities.

April 23, 2026
China Signals Nuclear Market Expansion with HAF003 QA Reform and Global Nuclear Pledge

China Mandates Full UDI Compliance for All Medical Devices by 2029

China’s NMPA mandates full UDI coverage for all medical devices by 2029, linking compliance to registration, reimbursement, and market access.

April 23, 2026
China Mandates Full UDI Compliance for All Medical Devices by 2029

China Issues GACC Order 280 Implementation Rules for Imported Food Registration

China clarifies GACC Order 280 rules for imported food registration and customs declarations ahead of June 2026 enforcement.

April 23, 2026
China Issues GACC Order 280 Implementation Rules for Imported Food Registration

China NMPA Issues 26 Medical Device Standards Affecting Orthopedics, IVDs, & Software

The 26 new medical device standards cover orthopedic implants, IVDs, active devices, and software risk management.

April 23, 2026
China NMPA Issues 26 Medical Device Standards Affecting Orthopedics, IVDs, & Software
Hong Kong Launches Pre-NDA Meetings Under the “1+” Drug Registration Mechanism

Hong Kong Launches Pre-NDA Meetings Under the “1+” Drug Registration Mechanism

Hong Kong’s Department of Health introduces Pre-NDA meetings to streamline new drug registrations under the “1+” mechanism.

April 15, 2026
Hong Kong Launches Pre-NDA Meetings Under the “1+” Drug Registration Mechanism
Hong Kong DH Mandates Medical Device Listing for Public Procurement by March 2026

Hong Kong DH Mandates Medical Device Listing for Public Procurement by March 2026

The Department of Health has mandated MDACS listing for public procurement eligibility — see which devices are affected and how to prepare.

April 15, 2026
Hong Kong DH Mandates Medical Device Listing for Public Procurement by March 2026

China CMDE Releases 2026 Revision Guideline for Aesthetic HA Fillers

China’s CMDE announced revisions to the registration review guideline for aesthetic sodium hyaluronate injectable fillers.

March 31, 2026
China CMDE Releases 2026 Revision Guideline for Aesthetic HA Fillers

China CDE Issues New 2026 Trial Guidelines for Insomnia, Neuropathic Pain, and Depression Drugs

China’s CDE released three 2026 trial guidelines on Phase III design for chronic insomnia, neuropathic pain, and depressive disorders.

March 31, 2026
China CDE Issues New 2026 Trial Guidelines for Insomnia, Neuropathic Pain, and Depression Drugs

NMPA CDE Releases Trial CMC Guideline for Preventive mRNA Vaccines — What Developers Must Prepare

NMPA CDE clarifies CMC expectations for preventive mRNA vaccines, focusing on LNP control, impurity management, and lifecycle comparability.

March 31, 2026
NMPA CDE Releases Trial CMC Guideline for Preventive mRNA Vaccines — What Developers Must Prepare

China CDE Issues Trial Guidance on CMC Changes for Cell Therapy Drugs

China’s CDE issued trial guidance on CMC lifecycle changes for cell therapies, emphasizing comparability and risk-based quality assessment.

March 31, 2026
China CDE Issues Trial Guidance on CMC Changes for Cell Therapy Drugs

China NMPA Applies ICH M14 to Non-Interventional Safety Studies using Real-World Evidence

China’s NMPA will apply ICH M14 to non-interventional real-world evidence safety studies initiated on or after its January 2026 announcement.

March 31, 2026
China NMPA Applies ICH M14 to Non-Interventional Safety Studies using Real-World Evidence

China Seeks Comments on Draft 2026 Class III Clinical Trial Approval Catalogue

The draft 2026 catalogue defines which Class III medical devices would require clinical trial approval before trial initiation.

March 31, 2026
China Seeks Comments on Draft 2026 Class III Clinical Trial Approval Catalogue

China’s 2026 Drug Regulation Revision: How State Council Decree No.828 Elevates Innovation and Tightens Lifecycle Accountability

China’s State Council has revised the Drug Administration Law implementation regulations under Decree No.828, introducing innovation incentives, expanded data protection, and stricter MAH obligations effective May 15, 2026.

March 31, 2026
China’s 2026 Drug Regulation Revision: How State Council Decree No.828 Elevates Innovation and Tightens Lifecycle Accountability

China NMPA Expands Fast-Track Access for Overseas Drugs

The NMPA has introduced faster review decisions, coordinated inspections, and improved temporary import pathways for urgently needed overseas-marketed drugs.

March 31, 2026
China NMPA Expands Fast-Track Access for Overseas Drugs
China medical device registrations 2023 annual report issued

China medical device registrations 2023 annual report issued

China medical device registrations 2023 annual report has been issued by the NMPA.

March 19, 2026
China medical device registrations 2023 annual report issued
More Diversity Thanks to Five Additional CCC-Certification Bodies

More Diversity Thanks to Five Additional CCC-Certification Bodies

The Chinese authority CNCA issued an announcement regarding the China Compulsory Certification Implementation Rules, which accredited five more certification organizations. The much criticized CQC-monopoly especially regarding electric devices now belongs to the past. The new organizations will primarily deal with the following product-groups:CTC (Guangdong Quality Testing CTC Certification Co. LTD): Cables, switches, electric lighting, low-voltage electrical componentsCQM (China Certification Center for Quality Mark): switches, electric hand tools, welding machines, other electric componentsCESI (China Electronic Standardization Institute): Audio/video equipmentCVC (Guangzhou VKAN Certification and Testing Co. Ltd.): Circuit breaker, assembly locking, connections for electric installations (and accessories), electric motors and household appliancesCGC (China General Certification Center): Household appliances.For further information please contact:Cisema China Certification GmbHTel.: +49 89 4161 7389 – 00Fax: +49 89 7484 9956info@cisema.dewww.cisema.com

March 18, 2026
More Diversity Thanks to Five Additional CCC-Certification Bodies
Certificate of Clearance for all Food Imports

Certificate of Clearance for all Food Imports

AQSIQ is planning to introduce an official certificate of clearance for all food imports.On 1.10.2017 announcement 83 2017 issued by AQSIQ (Administration for Quality, Safety, Inspection and Quarantine of China) will come into force. From then on, all food exported to China must be accompanied by an official certificate of clearance, which is to be issued by the competent authorities in the country of origin. Up to now, AQSIQ has not communicated any details, like which authorities are accepted by AQSIQ or which information is to be contained in the certificate.Many of China's trade partners have already filed a note of protest at WTO against this regulation and the feasibility of the Chinese plans is most uncertain according to expert opinions.We shall inform you immediately, if there are any news on the certificate of clearance.For further information please contact:Cisema GmbHTel.: +49 89 4161 7389 00Fax: +49 89 7484 9956info@cisema.dewww.cisema.com

March 18, 2026
Certificate of Clearance for all Food Imports
Motorcycle Helmets, E-Bikes and Electric Blankets Require CCC Certification

Motorcycle Helmets, E-Bikes and Electric Blankets Require CCC Certification

Starting August 1st 2018 motorcycle helmets, electric blankets, heating pads and similar flexible heaters required the CCC certification of the P.R. China.

March 18, 2026
Motorcycle Helmets, E-Bikes and Electric Blankets Require CCC Certification
NMPA: Funding for Testing of Medical Devices

NMPA: Funding for Testing of Medical Devices

On 17.11.2017 the NMPA (China Food and Drug Administration) published a notice announcing that fee-charging tests (also referred to as sponsored tests) are accepted as part of the NMPA registration of medical devices (No. 2017-187).

March 18, 2026
NMPA: Funding for Testing of Medical Devices
Automotive Implementation Rules for CCC-Certification Revised

Automotive Implementation Rules for CCC-Certification Revised

On August 21st 2014 the CNCA has publicized its announcement 31/2904 dealing with the revised implementation rules for CCC-certification of all automotive products, vehicles and their components.The most significant adjustments affect the product group “interior materials”: New products have been included in this group such as sound and thermal insulation materials used in the engine compartment. Also certain products that before were free of CCC will need certification under the new rule. This applies for instance to instrument panels, center consoles, floor mats and boot linings for sports cars and convertibles.Also there are new definitions regarding inspection and spare part management, some of which have already been in use by the Chinese certification organizations over the past years.All new regulations will be officially implemented on January 1, 2015.For more detailed information please contact us:Cisema China Certification GmbHTel.: +49 89 4161 7389-00Fax: +49 89 7484 9956info@cisema.dewww.cisema.de

March 18, 2026
Automotive Implementation Rules for CCC-Certification Revised
Registration of Cosmetics Might Soon be Possible Without Animal Tests

Registration of Cosmetics Might Soon be Possible Without Animal Tests

On 05.02.2018, the NIFDC (National Institutes for Food and Drug Control) – a unit under the NMPA (China Food and Drug Administration) – published a draft on two alternatives to animal testing: One for skin and one for eye irritation. The draft was open for public comment until 15.02.2018 and clearly indicates a major step towards the improvement of China’s technical cosmetics regulations and the replacement of animal testing in the future.

March 18, 2026
Registration of Cosmetics Might Soon be Possible Without Animal Tests
New NMPA Classification Catalogue for Medical Devices

New NMPA Classification Catalogue for Medical Devices

The NMPA published a new classification catalogue on August 31, 2017, with reference to more than 2,000 medical device examples.

March 18, 2026
New NMPA Classification Catalogue for Medical Devices
Introducing QR code for the China Energy Label (CEL)

Introducing QR code for the China Energy Label (CEL)

Introducing QR code for the China Energy Label (CEL).Back in spring the Chinese authorities AQSIQ (General Administration of Quality Supervision, Inspection and Quarantine of P.R. China) and NDRC (National Development and Reform Commission) drafted a change of the energy efficiency labeling. The intention is to make it easier for Chinese consumers to check on the energy efficiency of a product using online media.See below example:[caption id="attachment_1345" align="alignnone" width="182"] credit: 24.08.2016: https://www.cnca.gov.cn/xxgk/ggxx/2016/201608/W020160803588217825962.pdf[/caption]With immediate effect the labels have to be adjusted and get approval from the China Energy Label Center (CELC). Starting October 1st 2016 the import of products to China carrying the old efficiency label will be problematic.What has also changed is that web shops have to include the QR-code in their product description. Distributors have to do incoming goods inspections, to check on the CELC-registration and ensure that only conformal goods are traded.For more information please contact:Cisema China Certification GmbHTel.: +49 89 4161 7389 - 00Fax: +49 89 7484 9956info@cisema.dewww.cisema.com

March 18, 2026
Introducing QR code for the China Energy Label (CEL)
17 New Implementation Rules Published For the CCC-Certification

17 New Implementation Rules Published For the CCC-Certification

In their announcement 23/2014 from July 2014, the Chinese certification authority CNCA has publicized the release and implementation of seventeen new “implementation rules” required for CCC certification.The new implementation rules apply to electric devices, such as cables and lines, switches and switching devices, low voltage motors, welding tools, domestic appliances, audio, video and IT-equipment, as well as non-electrical products such as safety glass, agricultural tools, theft alarm systems and decoration products.The new regulations will be officially implemented on September 1, 2014. Existing certificates are still valid, but the appropriate adjustments to the new rules should be done at the next available opportunity.For more detailed information please contact us:Cisema China Certification GmbHTel.: +49 89 4161 7389-00Fax: +49 89 7484 9956info@cisema.dewww.cisema.de

March 18, 2026
17 New Implementation Rules Published For the CCC-Certification
China RoHS 2.0 „Compliance Management Catalog“

China RoHS 2.0 „Compliance Management Catalog“

China RoHS 2.0 „Compliance Management Catalog“ progressing to next phase.On February 3rd 2016 the responsible authorities (published an update on the regulation for hazardous substances - RoHS 2.0. The regulation is effective since July 1st 2016 (we reported).Originally a „Compliance Management Catalog“ was scheduled for publishing in October 2016. The content should provide a definition, whether a mandatory registration, and possibly an inspection of the manufacturer, will be introduced. So far there was no progress. On July 28th 2017 a consultation of the authority MIIT with business representatives ended. We expect to receive further information about the future approaches for China RoHS by end of this year.For further information please contact:Cisema China Certification GmbHTel.: +49 89 4161 7389 00Fax: +49 89 7484 9956info@cisema.dewww.cisema.de

March 18, 2026
China RoHS 2.0 „Compliance Management Catalog“
Prolonged Deadlines for the Renewal of NMPA Registration for Cosmetics

Prolonged Deadlines for the Renewal of NMPA Registration for Cosmetics

According to the NMPA Announcement on 1.9.2017, the processing time for application for renewal of the registration will be increased.

March 18, 2026
Prolonged Deadlines for the Renewal of NMPA Registration for Cosmetics
Recalls of Medical Device Regulation Updated

Recalls of Medical Device Regulation Updated

Recalls of Medical Device Regulation Updated .On September 2nd 2016 a new draft for handling recalls of medical devices has been released. The revision will replace the current regulation 82/2010 from the Chinese Ministry of Health dated 28.06.2010. It describes the key points leading to a recall.

  1. If the medical device poses hazardous risks
  2. If the medical device does not meet the regulation standards
  3. If during manufacturing and/or distribution violations of the current medical device regulations occur
  4. If any further adverse events ask for a recall

The draft also gives some guidelines for the management of recalls.

  1. When the recall occurs outside of China the appropriate departments of the NMPA have to be informed
  2. Within China:- Monitoring the safety of medical devices- Communication, reporting and close cooperation with the NMPA- Organization of the recall – assessment, if applicable relabelling, modification of the quality manual and/or software up-grades. Also of course repairs or replacement of the device and its disposal have to be taken care of.- Compensation- Penalties

When there is proof of the defectiveness of the device, and the NMPA-Legal-Agent fails to report to the NMPA, the NMPA may initiate the recall.Violation of the regulations can result in fines for the NMPA Legal Agent or even cost him his license.Recalls will be published in the NMPA database stating details of the product, its manufacturer and NMPA Legal Agent.For more information please contact us:Cisema GmbHTel.: +49 89 4161 7389 – 00Fax: +49 89 7484 9956info@cisema.dewww.cisema.com

March 18, 2026
Recalls of Medical Device Regulation Updated
NMPA – New Application Deadlines for Cosmetics

NMPA – New Application Deadlines for Cosmetics

NMPA – New Application Deadlines for Cosmetics. As of Sept.1st, 2017 the deadlines for the application of certificate renewals or changes will be as follows:

  • Renewal application must be submitted six months before expiry and not four months as before
  • Certificate changes, completions or corrections must be applied for ten months before expiry now. Renewal and change applications can be submitted at the same time.
  • The technical review by NMPA for a certificate renewal will take three months counting from the acceptance date of the application.

Further information on the above topic can be obtained from:Cisema GmbHTel.: +49 89 4161 7389 – 00Fax: +49 89 7484 9956info@cisema.dewww.cisema.com

March 18, 2026
NMPA – New Application Deadlines for Cosmetics
NMPA updates safety standards for cosmetic ingredients

NMPA updates safety standards for cosmetic ingredients

Die chinesische NMPA aktualisiert ihre Sicherheitsstandards für Inhaltsstoffe von Kosmetika ab dem 01.12.2016.

March 18, 2026
NMPA updates safety standards for cosmetic ingredients
Extension of Cross-Border E-Commerce Policy

Extension of Cross-Border E-Commerce Policy

During the meeting of the Chinese State Council on 20.09.2017, it was decided to extend the CBEC Policy Grace Period for a second time. The regulation allows the introduction of unregistered cosmetics, medical devices, infant formulas and health foods into Chinese cross-border cities until 31.12.2018.

March 18, 2026
Extension of Cross-Border E-Commerce Policy
Webinar: Opportunities in China's Medical Device Market

Webinar: Opportunities in China's Medical Device Market

Cisema gave a talk on medical device registration as part of the webinar on hosted by the U.S. Commercial Service on December 13, 2017.

March 18, 2026
Webinar: Opportunities in China's Medical Device Market
Import of small quantities also possible without CCC certificate

Import of small quantities also possible without CCC certificate

The BJCIQ published a procedure where CCC-liable goods may be imported in small quantities without CCC certification.

March 18, 2026
Import of small quantities also possible without CCC certificate
Important News Concerning CCC Marking

Important News Concerning CCC Marking

On 15.3.2018 the certification authority CNCA (Certification and Accreditation Administration of the P.R. China) announced on short term (announcement 10/2018) that the issuance of Permissions of Printing (PoP) for marking products with the CCC-logo (China Compulsory Certification) will be stopped as of 20.03.2018. According to the announcement, the owners of CCC certificates can start the marking immediately after receipt of the CCC certificate, provided they adhere to the guidelines. This procedure is similar to other well-known certification marks like E, CE or UL.

March 18, 2026
Important News Concerning CCC Marking
NMPA report on the registration of medical devices in 2013, 2014, 2015

NMPA report on the registration of medical devices in 2013, 2014, 2015

In 2015, the NMPA approved a total of 7,530 registrations for Class II and III products comparingly less than 2013 (7,875) and 2014 (8,834).

March 18, 2026
NMPA report on the registration of medical devices in 2013, 2014, 2015
New product catalog and new HS codes for the CCC certification

New product catalog and new HS codes for the CCC certification

New product catalog and new HS* codes for the CCC certification in PR ChinaIn two recent successive announcements by CNCA ** with the numbers 30 and 36 the scope of the CCC (China Compulsory Certification) certification is re-regulated. The new catalog of the top certification authority of CHina covers 22 product groups and 157 categories with current descriptions and definitions. In order to unify the implementation by the local customs offices better, additionally the list of affected HS codes (tariff codes) was brought up to date. Both lists are available in their original version only in Chinese.For more information about CCC certification in the VR China please get in touch with us.* = Harmonized System** = Certification and Accreditation Administration of China

March 18, 2026
New product catalog and new HS codes for the CCC certification
Additional CCC Certification Organization for Automotive Parts

Additional CCC Certification Organization for Automotive Parts

The CNCA (Certification and Accreditation Administration of the People's Republic of China) announced with its Notice No. 43-2017 that the CAQC (Cyberspace Administration of China) is allowed to process CCC (China Compulsory Certification) certification for product groups in the automotive sector.

March 18, 2026
Additional CCC Certification Organization for Automotive Parts
CCC Relevant Product Groups Updated

CCC Relevant Product Groups Updated

The Chinese certification authority CNCA (Certification and Accreditation Administration) has updated the list of product categories subject to CCC certification (China Compulsory Certification). Quite a few products have for instance been added to category 11 the “Motor vehicles and safety-relevant accessories”. It now includes insulation material in the engine compartment, floor mats, dashboards and devices for indirect vision. Category 20 “children products” now also contains child-seats.The previous 22 categories were reduced by two: Latex products and medical devices have been switched to NMPA (China Food and Drug Administration).Currently the CCC certification requirements apply to the following product groups:

  1. Electrical wires and cables
  2. Circuit switches, electric devices for protection or connection
  3. Low-voltage electrical apparatus
  4. Low power motors
  5. Electric tools
  6. Welding machines
  7. Household and similar electrical appliances
  8. Audio and video apparatus
  9. Information technology equipment
  10. Lighting apparatus
  11. Motor vehicles and safety-relevant accessories
  12. Motor vehicle tires
  13. Safety glasses
  14. Agricultural machinery
  15. Telecommunication terminal equipment
  16. Firefighting equipment
  17. Home safety protection products
  18. Wireless network devices
  19. Home decor and remodeling products
  20. Children products

If you have any more questions please contact us at:Cisema China Certification GmbHTel.: +49 89 4161 7389 - 00Fax: +49 89 7484 9956info@cisema.dewww.cisema.com

March 18, 2026
CCC Relevant Product Groups Updated
CCC "Light" for the Import of Vehicles

CCC "Light" for the Import of Vehicles

As of January 1, 2017, low volume imports will not be handled by the local CIQ any longer, but by the certification authorities.

March 18, 2026
CCC "Light" for the Import of Vehicles
CCC certification - dimensions of automotive interiors and insulating materials further specified

CCC certification - dimensions of automotive interiors and insulating materials further specified

CCC certification - dimensions of interior and insulation materials in the automotive sector further specified:On 01.01.2015 the new implementation guideline of the CNCA (Certification and Accreditation Administration of the People's Republic of China) for automotive interiors and insulating materials came into force (CNCA-C11-09:2014). With this regulation, a number of new components have been included in the scope of CCC certification (China Compulsory Certification). This led to an increase in the number of applications for CCC certification of products whose relevance was not clear.The competent Commission was therefore obliged to publish a further clarification of the Directive in December 2015. Based on last year's experience, especially with frame parts, components that completely cover a rectangle with the standard dimensions 356 x 100 mm are considered for certification. The final decision on compulsory certification clearly focuses on the geometry of the component. For example, a large component with several holes, one of which occupies more than 50% of the total area, may not be eligible for certification if the test sample cannot be cut in the required shape and size. In cases of doubt, the respective Chinese certification organisation makes an individual decision. Until now, smaller components were also accepted for certification if they reached the standard dimensions only in terms of length and width (e.g. in the form of a triangle). For affected components, certification can be maintained or cancelled if desired.Further information on the topics mentioned can be obtained from:Cisema China Certification GmbHTel.: +49 89 4161 7389-00Fax: +49 89 7484 9956info@cisema.dewww.cisema.de

March 18, 2026
CCC certification - dimensions of automotive interiors and insulating materials further specified
NMPA Issues Charging Standards for Drug and Medical Device Registration

NMPA Issues Charging Standards for Drug and Medical Device Registration

NMPA Issues Charging Standards for Drug and Medical Device RegistrationOn May 27, the China Food and Drug Administration ("NMPA") released its “Charging Standards for Registration of Drugs and Medical Devices” which come into force immediately. For pharmaceuticals, foreign companies will have to pay for clinical trials or marketing approvals, medical device companies have to pay for class II and III registration. This applies to new and change applications as well as the extension after five years.For small to micro enterprises in China doing medical innovation, the NMPA has set up a preferential policy of waiving registration fees and supplementary application fees.For more information please contact us at:Cisema China Certification GmbHTel.: +49 89 4161 7389 - 00Fax: +49 89 7484 9956info@cisema.dewww.cisema.com

March 18, 2026
NMPA Issues Charging Standards for Drug and Medical Device Registration
CBEC (Cross Border E-Commerce) - Deliveries Classified as Products for Personal Use

CBEC (Cross Border E-Commerce) - Deliveries Classified as Products for Personal Use

Online Trade - Deliveries Classified as Products for Personal Use.As of 1st January 2018 the Chinese customs authorities will treat all commodities traded through CBEC as articles for personal use. The reason is that commodities traded through CBEC are for private persons and usually have a low value and low quantities.Another five pilot cities for CBEC will be nominated: Besides Hangzhou, Tianjin, Shanghai, Chongqing, Zhengzhou, Guangzhou, Ningbo,Shenzhen, Fuzhou und Pingtan, there will now be added Chengdu, Dalian, Qingdao, Suzhou und Hefei.More details for the supervision will be published shortly. It can be assumed, however, that certain product groups which normally need registration or certification, can be traded and imported freely through CBEC. Among these commodities are:Ordinary cosmetics such as lotion, cream, facial mask, shampoo

  • Nutritional supplements such as vitamin and mineral preparations
  • CCC products such as coffee machines, vacuum cleaner
  • Freely traded medical devices such as electronic sphygmomanometer

It has not been decided yet if the new regulation also applies to infant formula.Further information on this topic can be obtained from:Cisema GmbHTel.: +49 89 4161 7389 – 00Fax: +49 89 7484 9956info@cisema.dewww.cisema.com

March 18, 2026
CBEC (Cross Border E-Commerce) - Deliveries Classified as Products for Personal Use
China Adjusts Import Control for Child Safety Seats and Alloy Wheels

China Adjusts Import Control for Child Safety Seats and Alloy Wheels

China Adjusts Its Import Control for Child Safety Seats and Alloy Wheels.With announcement 147/2014 the “General Administration of Quality Supervision, Inspection & Quarantine of China” (AQSIQ) and the “General Administration of Customs of China” (GACC) the entry/exit inspection-quarantine requirements have been imposed on car seats for children as well as automotive alloy wheels/parts.As of September 1st 2015 child safety seats are also subject to the mandatory CCC-certification.For more information please contact us:Cisema China Certification GmbHTel.: +49 89 4161 7389 – 00Fax: +49 89 7484 9956info@cisema.de www.cisema.de

March 18, 2026
China Adjusts Import Control for Child Safety Seats and Alloy Wheels
Abolition of animal testing in the approval of cosmetics

Abolition of animal testing in the approval of cosmetics

On 11.11.2016, the NMPA published Announcement 147, 2016 concerning the Neutral Red Uptake test as an alternative to animal experiments

March 18, 2026
Abolition of animal testing in the approval of cosmetics
Energy efficiency labeling requirements for electric motors

Energy efficiency labeling requirements for electric motors

Energy efficiency labeling requirements for electric motors in the People's Republic ChinaThe two recent successive announcements with numbers 136 and 137 of the ELAC (Energy Label Administration of China) re-regulate the energy efficiency labeling of electric motors in the People's Republic China. In addition, the update of GB standard 18613-2006 with number GB 18613-2012 was implemented without transition. Currently, the old label is accepted still, but for the next annual report to the ELAC, the current standard must be specified. For this reason, the type of tests must be carried out according to GB 18613-2012 as soon as possible.Currently, the energy efficiency labeling is valid for electric drives for 3-phase asynchronous motors. In the future, synchronous motors with permanent magnets and 3-phase induction motors will be affected also.More information on energy efficiency labeling in the VR China can be obtained from us. Please let us know if you need anything.

March 18, 2026
Energy efficiency labeling requirements for electric motors
NMPA Annual Report

NMPA Annual Report

China Food and Drug Administration (NMPA) report on registration of medical devices in China.NMPA recently published its Annual Report 2016 on medical device registration. The number of registrations in Class II, III and IVD has increased to 8.653, which is a plus of 14.9 % compared to the previous year. The retracement suffered in 2015 was due to the various regulatory changes dating back to 2014 as well as the increase of application fees in 2015, but the current figures have reached the 2014 level again.A large percentage of applications for the registration of medical devices and IVD comes from abroad. Class II had 3.095 applications from abroad, which is an increase of 2% compared to 2015 and in Class III there were 2.818 applications, an increase of even 15%.The P.R. China continues to promote the import of high-end and high-cost medical devices from abroad. The top five class II and III product groups of foreign origin to be registered in 2016 were:

  1. Implanted material and artificial organs (509) – was on place 2 in 2015
  2. Medical optical instruments, devices, and endoscopes (406)
  3. Medical electronic instruments and devices (285)
  4. Medical polymer material and products (249)
  5. Devices and instruments for OR, IR, and Doctor’s consulting room (141) – superseded dental care equipment.

According to the NMPA report 2016, top of the list of registrations of foreign class II and III products (including IVD) were the USA followed by Germany, places 3, 4 and 5 were held by Japan, United Kingdom and Korea.Further information concerning this topic can be obtained from:Cisema GmbHTel.: +49 89 4161 7389–00Fax: +49 89 7484 9956info@cisema.dewww.cisema.com

March 18, 2026
NMPA Annual Report

Get in Touch with our Certifications team

And discover how we can support you in getting your products certified for China.

Request Proposal